<DOC>
	<DOCNO>NCT01662999</DOCNO>
	<brief_summary>The purpose study evaluate whether pharmacokinetics ( body concentrations/metabolism drug ) Saxagliptin Dapagliflozin affect administer together</brief_summary>
	<brief_title>Drug Interaction Study Saxagliptin Combination With Dapagliflozin Healthy Participants</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Saxagliptin</mesh_term>
	<criteria>Healthy subject determine clinically significant deviation normal medical history , Physical Examination , vital sign , 12lead ECG , clinical laboratory determination Body mass index ( BMI ) 18 30 kg/m2 Men woman , age 18 45 year Women childbearing potential must use acceptable method highly effective birth control History chronic recurrent urinary tract infection females History allergy adverse reaction Dipeptidyl peptidaseIV ( DPP4 ) Sodiumglucose transporter type 2 ( SGLT2 ) inhibitors Any significant acute chronic medical illness Current recent gastrointestinal disease Any major surgery within 4 week study drug administration Prior exposure saxagliptin dapagliflozin relate drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>